| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2001;32:1336.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Department of Neurological Surgery (E.T., Y.K., Y.S., T.K.), Nihon University School of Medicine, Tokyo, Japan, and the Neuroprotection Research Laboratory (E.H.L.), Departments of Neurology and Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, Mass.
Correspondence to Dr Tsuneo Kano, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. E-mail tsuneok{at}med.nihon-u.ac.jp
Background and PurposeWe used a rat model of thromboembolic stroke to evaluate whether hypertension increases the incidence of hemorrhage after fibrinolysis with tissue plasminogen activator (tPA).
MethodsIn this model, a microclot suspension was injected into the middle cerebral artery territory to induce focal ischemia. Reperfusion was induced in spontaneously hypertensive rats (SHR) by administering tPA (10 mg/kg) intravenously at 2 hours or 6 hours after the onset of thromboembolic focal ischemia. In untreated control rats, saline was administered at 2 hours after ischemia.
ResultsHemorrhagic transformation was observed only in rats that received tPA at 6 hours (6 of 8 rats [75%]). Reduction of mean arterial blood pressure from 122±3 to 99±2 mm Hg with hydralazine, given to SHR for 1 week before ischemia, significantly decreased the incidence of hemorrhage in 2 of 11 rats (18%). tPA reduced infarct volumes, but cotreatment with hydralazine did not result in further protection.
ConclusionsThis study demonstrates that in this rat thromboembolic model of stroke, tPA-induced hemorrhage is dependent on blood pressure and that pharmacological reduction of hypertension during fibrinolysis can reduce the risk of hemorrhagic transformation.
Key Words: cerebral hemorrhage fibrinolysis hypertension stroke rats
This article has been cited by other articles:
![]() |
Y. Loh, A. Towfighi, D. S. Liebeskind, D. L. MacArthur, P. Vespa, N. R. Gonzalez, S. Tateshima, S. Starkman, J. L. Saver, Z.-S. Shi, et al. Basal Ganglionic Infarction Before Mechanical Thrombectomy Predicts Poor Outcome Stroke, October 1, 2009; 40(10): 3315 - 3320. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuroiwa, G. Xi, Y. Hua, T. N. Nagaraja, J. D. Fenstermacher, and R. F. Keep Development of a Rat Model of Photothrombotic Ischemia and Infarction Within the Caudoputamen Stroke, January 1, 2009; 40(1): 248 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saguchi, H. Onoue, M. Urashima, T. Ishibashi, T. Abe, and H. Furuhata Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke: Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model Stroke, March 1, 2008; 39(3): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function Stroke, December 1, 2003; 34(12): 2975 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castellanos, R. Leira, J. Serena, J. M. Pumar, I. Lizasoain, J. Castillo, A. Davalos, and G. F. Hamann Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke * Editorial Comment Stroke, January 1, 2003; 34(1): 40 - 46. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |